ResMed (NYSE: RMD, ASX: RMD) is a pioneering force behind innovative solutions that revolutionize healthcare. Our focus is on empowering individuals to lead healthier, higher-quality lives by offering cloud-connected medical devices that effectively treat sleep apnea, COPD, and other chronic ailments. Through comprehensive out-of-hospital software platforms, we extend our support to healthcare professionals and caregivers, ensuring people can receive the best care in the comfort of their chosen setting. Operating in over 120 countries, our commitment lies in enhancing the quality of life, curbing the impact of chronic diseases, and driving down healthcare costs for consumers and systems alike.